How should patients with unstable angina and non-ST-segment elevation myocardial infarction be managed? A
Niteesh K Choudhry1, Jeffrey M Singh, Alan Barolet
1Harvard Medical School and Brigham and Women's Hospital, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA. choudhry@fas.harvard.edu
Insights
An invasive strategy for unstable angina/non-ST-segment elevation myocardial infarction reduces re-infarction and hospital readmissions. This approach should be considered for all patients, especially those with ST-segment depression.
Area of Science:
- Cardiology
- Clinical Medicine
- Interventional Cardiology
Background:
- Unstable angina and non-ST-segment elevation myocardial infarction (MI) management involves invasive or conservative strategies.
- The superiority of these management strategies remains unclear.
Purpose of the Study:
- To compare the efficacy of invasive versus conservative management strategies for patients with unstable angina or non-ST-segment elevation MI.
Main Methods:
- Systematic review and meta-analysis of randomized controlled trials (RCTs) identified through MEDLINE and EMBASE searches.
- Included seven RCTs with a total of 9212 patients, focusing on follow-up data of at least 3 months.
Main Results:
- An invasive strategy significantly reduced fatal or nonfatal re-infarction (OR 0.73; 95% CI: 0.61 to 0.88) and hospital readmissions (OR 0.67; 95% CI: 0.48 to 0.94).
- All-cause mortality was not significantly reduced (OR 0.96; 95% CI: 0.72 to 1.27).
- Greater benefits from invasive strategies were observed in patients with ST-segment depression and those undergoing revascularization.
Conclusions:
- An invasive strategy is effective in reducing re-infarction and readmission rates for unstable angina/non-ST-segment elevation MI patients.
- All-cause mortality was not significantly impacted.
- An invasive approach is recommended for all patients with unstable angina/non-ST-segment elevation MI, particularly those with ST-segment depression.
Purpose:
Patients with unstable angina or non-ST-segment elevation myocardial infarction (MI) may be managed with either an "invasive" or "conservative" strategy. It is unclear which of these strategies is superior.
Methods:
We identified studies with MEDLINE and EMBASE searches (1966-September 2003) and by reviewing reference lists. Studies were included if they were randomized controlled trials comparing management strategies for patients in the early post-unstable angina/non-ST-segment elevation MI period and had follow-up data for at least 3 months.
Results:
Seven trials that randomized a total of 9212 patients were included. The pooled odds ratio (OR) for all-cause mortality was 0.96 (95% confidence interval [CI]: 0.72 to 1.27). The occurrence of fatal or nonfatal re-infarction was reduced with an invasive strategy (OR 0.73; 95% CI: 0.61 to 0.88) as was readmission to hospital (OR 0.67; 95% CI: 0.48 to 0.94). The endpoints of nonfatal MI and the composite of death or nonfatal MI showed nonsignificant trends favoring an invasive strategy. Trials that included a higher proportion of patients with ST-segment depression on admission and trials in which a larger proportion of patients underwent revascularization showed a greater magnitude of benefit for an invasive strategy.
Conclusion:
For patients with unstable angina/non-ST-segment elevation MI, an invasive strategy reduces rates of fatal or nonfatal re-infarction and hospital readmission, but not all-cause mortality, when compared with a noninvasive strategy. These results suggest that an invasive management strategy should be considered for all patients with unstable angina/non-ST-segment elevation MI and perhaps in particular those with ST-segment depression.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Angina II: Classification
Angina IV: Management
Angina V: Nursing Management
